Efficacy of meningococcal serogroup C conjugate vaccine in teenagers and toddlers in England

Lancet

Volumn 357, Issue 9251, 2001, Pages 195-196

  Ramsay, Mary E ^a   Andrews, Nick ^a   Kaczmarski, Edward B ^b   Miller, Elizabeth ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b WITHINGTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ARTICLE; BLOOD GROUP TYPING; DRUG EFFICACY; DRUG SURVEILLANCE PROGRAM; HUMAN; IMMUNOGENICITY; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SAFETY; UNITED KINGDOM; VACCINATION;

EID: 0035915614     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)03594-7     Document Type: Article

References (5)

1. Avalição do efeito protetor de vacina polissacaridica antimeningocócica do grupo C, em crianças de a 36 meses
2. Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers
3. Evaluation of the applied biosystems automated Taqman polymerase chain reaction system for the detection of meningococcal DNA
4. Estimation of vaccine effectiveness using the screening method
5. Safety of meningococcal group C conjugate vaccines